Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/1996
08/15/1996WO1996024364A2 Antimicrobial composition composed of controlled release glasses
08/15/1996WO1996024359A1 Novel pharmaceutical formulation
08/15/1996WO1996024357A1 Novel glucocorticoid response elements
08/15/1996WO1996024355A1 Novel pharmaceutical combination
08/15/1996WO1996024354A1 Novel pharmaceutical composition
08/15/1996WO1996018391A3 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
08/15/1996WO1996016652A3 Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections
08/15/1996WO1996013590A3 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
08/15/1996WO1994020062A3 Balanoids as protein kinase c inhibitors
08/15/1996CA2212682A1 Delivery of exogenous compounds
08/15/1996CA2212533A1 Multifunctional enzyme
08/15/1996CA2212464A1 Potentiators of antibacterial agents
08/15/1996CA2212437A1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996CA2212379A1 Novel glucocorticoid response elements
08/15/1996CA2212372A1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
08/15/1996CA2211464A1 Novel pharmaceutical composition
08/15/1996CA2211409A1 Novel pharmaceutical formulation
08/14/1996EP0726315A1 Epstein-Barr virus DNA sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests
08/14/1996EP0726274A2 G-cap stabilized oligonucleotides
08/14/1996EP0726270A1 Derivatives of 1,6-naphthyridine carboxylic acids
08/14/1996EP0726062A2 Center dispense suture package
08/14/1996EP0725831A1 Viral vector with bovine viral diarrhea virus (bvdv) antigens
08/14/1996EP0725830A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
08/14/1996EP0725825A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
08/14/1996EP0725824A1 Immunodominant human t-cell epitopes of hepatitis c virus
08/14/1996EP0725792A1 RECOMBINANT PilC PROTEINS, PROCESS FOR PRODUCING THEM AND THEIR USE
08/14/1996EP0725783A1 2-(pyrazol-3-yl)carbapenem derivatives
08/14/1996EP0725651A1 Hemoregulatory peptides
08/14/1996EP0725645A1 COMPOSITIONS FOR USE IN THE REGULATION OF SUBNORMAL pH VALUES IN THE INTESTINAL TRACT AND FOR TREATMENT OF BOWEL DISEASES
08/14/1996EP0725641A1 Novel enzyme inhibitors, their synthesis, and methods for use
08/14/1996EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
08/14/1996EP0725634A1 Plaster for the treatment of nail mycoses
08/14/1996EP0725629A1 Liposomal defensins
08/14/1996EP0636115B1 Novel bis-phenyl-hexenes
08/14/1996EP0595794B1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof
08/14/1996EP0575317B1 Recombinant anticoccidial vaccine
08/14/1996EP0396559B1 Hiv peptides, artificial hiv antigens and immunoassay kits
08/14/1996CN1128996A Substituted arylthioalkylthiopyridines
08/14/1996CN1128995A Novel Quinolone carboxylic acid derivative
08/13/1996US5545750 Retroviral protease inhibiting compounds
08/13/1996US5545736 6-thiono-5,6-dihydro-dibenz[B,E] azepin-11-one-11-oximes
08/13/1996US5545723 Amino acid sequence where valine at position 101 is replaced with phenylalanine, tyrosine, tryptophan or histidine; diplayes an antiviral activity, that is atleast partially neutralized by antibodies to wild type interferon-beta
08/13/1996US5545662 Used to accelerate recovery from neutropenia accompanying radio or chemotherapy, bone marrow transplantation, or infections
08/13/1996US5545654 Bactericides
08/13/1996US5545653 Anti-viral compounds
08/13/1996US5545652 Triazole and imidazole compounds and their use as antifungal therapeutic agents
08/13/1996US5545642 Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid and 1-(2-fluorocyclopropyl)-naphthridonecarboxylic acid
08/13/1996US5545640 Viricides, hiv; aids
08/13/1996US5545637 Process for preparing pharmaceutical compositions containing crystalline anhydrous mycophenolate mofetil salts
08/13/1996US5545624 Useful in treating bacterial or mycoplasmic infections
08/13/1996US5545553 Genetic engineering
08/13/1996US5545405 Administering recombinant antibody glycosylated by chinese hamster ovary cell
08/13/1996US5545404 Method for treating a mammal suffering from a T-cell medicated disorder with a CHO-Glycosylated antibody
08/13/1996US5545403 Method for treating a mammal by administering a CHO-glycosylated antibody
08/13/1996CA2100066C Michellamines useful as antiviral agents, composition and method of treatment
08/13/1996CA1338518C Antibody heteroconjugates for the killing of hiv-infected cells
08/11/1996CA2169152A1 Center dispense suture package
08/08/1996WO1996023885A1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
08/08/1996WO1996023788A1 Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
08/08/1996WO1996023523A1 Novel hemostatic composition
08/08/1996WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof
08/08/1996WO1996023509A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
08/08/1996WO1996023505A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
08/08/1996WO1996023500A1 New stable ganelic formulations containing an acid-labile benzimidazol compound, and production process
08/08/1996WO1996023479A2 Anti-adhesive active principles
08/08/1996WO1996023410A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9
08/08/1996WO1996015798A3 Use of bioassimilable boron compounds for the control of subviral pathogenic agents
08/08/1996DE19503423A1 Antiadhäsive Wirkstoffe Anti-adhesive agents
08/08/1996CA2211973A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
08/08/1996CA2211783A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
08/08/1996CA2210928A1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
08/08/1996CA2208603A1 Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
08/07/1996EP0724651A1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus
08/07/1996EP0724645A1 Antifungal antibiotic cepacidine a
08/07/1996EP0724644A1 Dna encoding 1,3-beta-d glucan synthase subunits
08/07/1996EP0724602A1 MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS
08/07/1996EP0724587A1 Ring-expanded nucleosides and nucleotides
08/07/1996EP0724586A1 Process for preparing n-(2,6-dichloro-3-methylphenyl)-5-7-dihalo 1,2,4]triazolo 1,5a]pyrimidine-2-sulfonamide by cyclization and halo-dehydroxylation
08/07/1996EP0724581A1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
08/07/1996EP0724571A1 Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides
08/07/1996EP0724570A1 Amidino derivatives useful as nitric oxide synthase inhibitors
08/07/1996EP0724455A1 Method for expression and purification of p2 protein from haemophilus influenzae type b
08/07/1996EP0724445A1 The use of inositoltrisphosphate for the preparing of medicaments
08/07/1996EP0724432A1 Methods and compositions for microencapsulation of antigens for use as vaccines
08/07/1996EP0724387A1 Treatment of chronic anti-inflammatory diseases by angiotension ii receptor antagonists
08/07/1996EP0515561B1 An antiviral agent derived from the hull of the kukui nut
08/07/1996CN1128538A Tandem synthetic HIV-1 peptides
08/06/1996US5543422 Heterocyclic amines
08/06/1996US5543418 Innovative technique for immunosuppresion involving administration of rapamycin loaded formed blood elements
08/06/1996US5543414 Viricides
08/06/1996US5543413 Heterocyclic thioamides and related analogs as antiviral agents with a unique mode of action
08/06/1996US5543410 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof
08/06/1996US5543408 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
08/06/1996US5543400 Antibiotics
08/06/1996US5543304 Expressing the protein fused to a nontoxic protein from recombinant dna; isolating using chromatography to bind nontoxic protein; separation
08/01/1996WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
08/01/1996WO1996022994A1 Bismuth compounds
08/01/1996WO1996022965A1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides
08/01/1996WO1996022955A1 Improved synthesis of cyclopropylacetylene
08/01/1996WO1996022784A1 Novel antifungal cyclohexapeptides
1 ... 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 ... 1798